Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04599478
PHASE2/PHASE3

Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

This study will compare the effectiveness of behavioral and pharmacologic treatments, alone and in combination, for the treatment of loss-of-control eating and weight following bariatric surgery. This is an acute treatment comparing behavioral weight loss alone or in combination with combination naltrexone/bupropion medication.

Official title: Pharmacological and Behavioral Treatments to Treat Loss-of-Control Eating and Improve Weight Outcomes After Bariatric Surgery: Acute (Stage 1)

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

160

Start Date

2021-06-29

Completion Date

2027-01

Last Updated

2026-03-27

Healthy Volunteers

No

Interventions

DRUG

Naltrexone and Bupropion medication

NB medication will be taken daily in pill form.

BEHAVIORAL

Behavioral Weight Loss

Behavioral Weight Loss (BWL) counseling includes weekly sessions.

OTHER

Placebo

Placebo will be inactive and taken daily in pill form.

Locations (1)

Yale Department of Psychiatry

New Haven, Connecticut, United States